Business Context and Reporting Period
This Form 8-K was filed by Pavmed Inc. on October 25, 2021. The report serves as a current disclosure pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The registrant is an emerging growth company incorporated in Delaware, with principal executive offices in New York, New York.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is a significant executive appointment:
- Sunny Webb, a Silicon Valley technology executive, has been appointed as:
- Chief Technology Officer (CTO) of Veris Health Inc., a majority-owned subsidiary of Pavmed Inc.
- VP, Data & Analytics of Pavmed Inc.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on future performance, or discussion of risks and contingencies. The disclosure is limited to the personnel change described above. The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the background and prior experience of Sunny Webb in the technology sector.
- Confirm the strategic role of Veris Health Inc. within Pavmed's overall business model.
- Review the attached press release (Exhibit 99.1) for additional details on the appointment.
- Note that this filing does not impact the company's financial position or provide updated financial guidance.